Danish Medicines Agency Issues EuroPharma GMP Non-Compliance Report

EuroPharma has received a GMP non-compliance statement from the Danish Medicines Agency (DMA).

According to the statement, an inspection at the firm’s plant in Denmark revealed significant GMP violations. The firm deliberately hid information and falsified the expiry date on medicinal products.

The DMA has already recalled several medicinal products that the agency consider affected by incorrect labeling.